A comprehensive study of phospholipid fatty acid rearrangements in metabolic syndrome: correlations with organ dysfunction.


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
15 06 2020
Historique:
received: 20 12 2019
accepted: 07 04 2020
pubmed: 19 4 2020
medline: 24 8 2021
entrez: 19 4 2020
Statut: epublish

Résumé

The balance within phospholipids (PLs) between saturated fatty acids and monounsaturated or polyunsaturated fatty acids is known to regulate the biophysical properties of cellular membranes. As a consequence, in many cell types, perturbing this balance alters crucial cellular processes, such as vesicular budding and the trafficking/function of membrane-anchored proteins. The worldwide spread of the Western diet, which is highly enriched in saturated fats, has been clearly correlated with the emergence of a complex syndrome known as metabolic syndrome (MetS). MetS is defined as a cluster of risk factors for cardiovascular diseases, type 2 diabetes and hepatic steatosis; however, no clear correlations have been established between diet-induced fatty acid redistribution within cellular PLs and the severity/chronology of the symptoms associated with MetS or the function of the targeted organs. To address this issue, in this study we analyzed PL remodeling in rats exposed to a high-fat/high-fructose diet (HFHF) over a 15-week period. PL remodeling was analyzed in several organs, including known MetS targets. We show that fatty acids from the diet can redistribute within PLs in a very selective manner, with phosphatidylcholine being the preferred sink for this redistribution. Moreover, in the HFHF rat model, most organs are protected from this redistribution, at least during the early onset of MetS, at the expense of the liver and skeletal muscles. Interestingly, such a redistribution correlates with clear-cut alterations in the function of these organs.This article has an associated First Person interview with the first author of the paper.

Identifiants

pubmed: 32303571
pii: dmm.043927
doi: 10.1242/dmm.043927
pmc: PMC7328154
pii:
doi:

Substances chimiques

Dietary Sugars 0
Fatty Acids 0
Phospholipids 0
Fructose 30237-26-4

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2020. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Références

Hepatology. 2005 Jun;41(6):1313-21
pubmed: 15915461
Respir Res. 2006 Aug 28;7:113
pubmed: 16938132
FEBS Lett. 2017 Sep;591(18):2720-2729
pubmed: 28686302
J Anim Physiol Anim Nutr (Berl). 2008 Jun;92(3):272-83
pubmed: 18477307
J Exp Biol. 2018 Jul 6;221(Pt 13):
pubmed: 29980597
Trends Cell Biol. 2015 Jul;25(7):427-36
pubmed: 25906908
J Cardiovasc Magn Reson. 2008 Feb 13;10:10
pubmed: 18275595
Apoptosis. 2009 Dec;14(12):1484-95
pubmed: 19421860
Am J Physiol Lung Cell Mol Physiol. 2001 Feb;280(2):L334-41
pubmed: 11159013
Biochim Biophys Acta. 2006 Sep;1761(9):1022-9
pubmed: 16860597
J Mol Cell Cardiol. 2013 Apr;57:119-28
pubmed: 23376037
Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16381-5
pubmed: 21930939
Nutr Metab (Lond). 2016 Oct 4;13:65
pubmed: 27708685
Biochim Biophys Acta. 2012 Sep;1822(9):1442-52
pubmed: 22627108
Biochim Biophys Acta Mol Basis Dis. 2018 Sep;1864(9 Pt B):3069-3084
pubmed: 29960042
Int J Mol Sci. 2011;12(4):2408-33
pubmed: 21731449
Science. 2014 Aug 8;345(6197):693-7
pubmed: 25104391
J Mol Cell Cardiol. 2011 Jun;50(6):940-50
pubmed: 21385587
Nutrients. 2013 Apr 12;5(4):1218-40
pubmed: 23584084
Curr Diabetes Rev. 2012 Jan;8(1):2-17
pubmed: 22414056
Diabetes Care. 2005 Oct;28(10):2541-2
pubmed: 16186295
J Lipid Res. 1985 Apr;26(4):507-12
pubmed: 4009068
Br J Pharmacol. 1998 Feb;123(4):694-700
pubmed: 9517389
PLoS One. 2013 Nov 07;8(11):e79736
pubmed: 24244551
Circ Res. 2016 May 27;118(11):1752-70
pubmed: 27230640
Circulation. 1985 Mar;71(3):481-6
pubmed: 3971522
Nutr Metab (Lond). 2016 Feb 25;13:15
pubmed: 26918024

Auteurs

Amélie Bacle (A)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Linette Kadri (L)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Spiro Khoury (S)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Romain Ferru-Clément (R)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Jean-François Faivre (JF)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.
Laboratoire "Signalisation et Transports Ioniques Membranaires (STIM; EA 7349)", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Christian Cognard (C)

Laboratoire "Signalisation et Transports Ioniques Membranaires (STIM; EA 7349)", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Jocelyn Bescond (J)

Laboratoire "Signalisation et Transports Ioniques Membranaires (STIM; EA 7349)", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Amandine Krzesiak (A)

Laboratoire "Signalisation et Transports Ioniques Membranaires (STIM; EA 7349)", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Hugo Contzler (H)

Laboratoire "Signalisation et Transports Ioniques Membranaires (STIM; EA 7349)", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Nathalie Delpech (N)

Laboratoire "Mobilité Vieillissement et Exercice (MOVE; EA 6314)", Université de Poitiers, 8, Allée Jean Monnet, 86073 Poitiers, France.

Jenny Colas (J)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.
Laboratoire "Signalisation et Transports Ioniques Membranaires (STIM; EA 7349)", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Clarisse Vandebrouck (C)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.
Laboratoire "Signalisation et Transports Ioniques Membranaires (STIM; EA 7349)", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Stéphane Sébille (S)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.
Laboratoire "Signalisation et Transports Ioniques Membranaires (STIM; EA 7349)", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France.

Thierry Ferreira (T)

Laboratoire "Lipotoxicity and Channelopathies (LitCh) - ConicMeds", Université de Poitiers, 1, rue Georges Bonnet, 86073 Poitiers, France thierry.ferreira@univ-poitiers.fr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH